Rallybio Corporation (RLYB)
NASDAQ: RLYB · Real-Time Price · USD
7.54
+0.74 (10.88%)
At close: Feb 27, 2026, 4:00 PM EST
7.41
-0.13 (-1.76%)
After-hours: Feb 27, 2026, 7:33 PM EST
Rallybio Market Cap
Rallybio has a market cap or net worth of $39.81 million as of February 27, 2026. Its market cap has increased by 32.37% in one year.
Market Cap
39.81M
Enterprise Value
-19.31M
1-Year Change
32.37%
Ranking
Category
Stock Price
$7.54
Market Cap Chart
Since the IPO on July 29, 2021, Rallybio's market cap has decreased from $405.60M to $39.81M, a decrease of -90.18%. That is a compound annual growth rate of -39.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 39.81M | 37.37% |
| Dec 31, 2025 | 28.98M | -27.23% |
| Dec 31, 2024 | 39.83M | -55.91% |
| Dec 29, 2023 | 90.33M | -63.67% |
| Dec 30, 2022 | 248.60M | -18.90% |
| Dec 31, 2021 | 306.52M | -24.43% |
| Jul 29, 2021 | 405.60M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| RenovoRx | 33.89M |
| Actinium Pharmaceuticals | 33.69M |
| ABVC BioPharma | 33.58M |
| Atara Biotherapeutics | 33.02M |
| Rein Therapeutics | 32.60M |
| Werewolf Therapeutics | 32.09M |
| Tempest Therapeutics | 31.01M |
| Passage Bio | 30.55M |